The PFA-100® System measures the complex process of primary hemostasis and aids in the rapid detection of platelet dysfunction. It is the first commercially available in vitro testing system to incorporate high-shear flow in which the process of platelet adhesion and aggregation following a vascular injury is simulated in-vitro.

The PFA-100 System provides automated assessment for inherited, acquired, or drug-induced platelet dysfunction.

• Helps detect inherited, acquired and drug-induced platelet dysfunction
• Screening test for patients with impaired primary hemostasis, such as von Willebrand disease1
• Verifies efficacy of desmopressin acetate (DDAVP) therapy in pre-surgical patients2
• Assesses the platelet dysfunction due to the effect of Aspirin
• Evaluates platelet dysfunction in children over 1 year of age3
• Evaluates platelet dysfunction in multiple clinical settings, such as presurgical screening, high-risk pregnancy and menorrhagia